Breaking News

QIAGEN Expands Next-gen Sequencing Applications

Launches QIAxpert instrument and CLC Cancer Research Workbench

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

QIAGEN N.V. has launched two new products aimed at addressing workflow challenges in next-generation sequencing (NGS) applications. The QIAxpert instrument is designed to accelerate quantification and quality control of DNA and RNA samples, and the new CLC Cancer Research Workbench is a bioinformatics software suite designed for rapid analysis, visualization, and interpretation of advanced NGS data in cancer research.   QIAxpert is a high-speed UV/VIS spectrophotometer that enables labs to asses...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters